Genentech, a member of the Roche Group announced the U.S. Food and Drug Administration (FDA) has approved the Vabysmo (faricimab-svoa) 6.0 mg single-dose prefilled...
Genentech, a member of the Roche Group , announced positive results from the Phase II FENopta study evaluating investigational oral fenebrutinib in adults with...
PicnicHealth, a patient-centered health technology company, announced its intent to globally expand its partnership with Roche and Genentech to accelerate neurological disease research through...
Genentech, a member of the Roche Group, announced that the U.S. Food and Drug Administration (FDA) has approved Polivy in combination with Rituxan, cyclophosphamide,...
Genentech, a member of the Roche Group, announced new data from the Phase III IMbrave050 study that show Tecentriq plus Avastin demonstrated a statistically significant...
